Kathleen Conway et al. suggested that racial differences in the methylation of cancer-related genes are detectable in both tumor cells and peripheral blood leukocytes from breast cancer cases [34] The other explanation is the use of different/unclear cut-off values in SOX2 expression. The gene discussed is SOX2; the disease is breast cancer.